The Department of Commerce has determined that Pioneer Natural Resources and Enterprise Products Partners could start exporting condensate, an ultralight type of crude
The $3.5 billion merger highlights how little has changed in the stubbornly old-fashioned way we buy and sell houses
The Supreme Court has seemed hesitant to hear a gun-rights case for the past four years, but that spell looks likely to end.
OKCupid does all sorts of interesting research on its users—just like Facebook
“Procrastination and inattention” cause homeowners to leave money on the table, says a prize-winning academic research paper
Remember when Wolf Blitzer talked to Jessica Yellin’s hologram in 2008? HologramUSA envisions so much more
A lot more workers, especially in high-earning professions, are overworking than they used to -- and most are men.
Thanks to a quirk in Federal law, most students of the company's shuttered for-profit schools can't do anything about their student debt.
AirSign, the skywriting company behind a recent Comic-Con campaign, sees an opportunity in airborne social media
King of Prussia, Pa.
Founders: Dr. Robert Lefkowitz and Dr. Howard Rockman
VC Investment over the last four quarters: $26.1 million
Trevena, founded in January 2008, is a drug discovery company developing pharmaceuticals that target what are known as G-protein coupled receptors. Such drugs make up more than 40% of marketed drugs today, according to Trevena. The company's drug discovery platform is based on research from Duke University Medical Center, including that of founder and National Medal of Science winner Robert Lefkowitz.
Key to startup success: "We've been able to generate the strong investor support for this idea [because] the technology and the opportunity here is very, very unique, and the possibility of unlocking new areas of biology is so significantly different from what's currently out there."